Writer must have a basic understanding of modern biology and chemistry and advanced knowledge (e.g., a graduate degree) in one or more of the following subject areas: biochemistry, molecular biology, cellular biology, biophysics, genetics, immunology, neuroscience, organic chemistry, chemical kinetics, pharmacology, animal physiology, medicine, public health. Calibr-Skaggs’ drug development portfolio spans a broad range of human diseases, including cancer, autoimmunity and inflammatory diseases, metabolic and cardiovascular diseases, infectious and neglected tropical diseases, as well as age-related and degenerative diseases.